U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07595159) titled 'A Study of BW-20507 in Chinese Healthy Subjects and Subjects With Chronic Hepatitis B' on March 29.
Brief Summary: Phase 1 Study of BW-20507 in Healthy Subjects and Patients With Chronic Hepatitis B. Ia involved a single ascending dose study where healthy participants were administered one dose of BW-20507 or placebo subcutaneously. Ib involved a multiple ascending dose study where participants with chronic hepatitis B virus infection were administered with multiple doses of BW-20507 SC
Study Start Date: June 24, 2024
Study Type: INTERVENTIONAL
Condition:
Chronic Hepatitis B
Intervention:
DRUG: Placebo
Solution for injection
...